Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Treasury Shares (2016 - 2024)

Aptevo Therapeutics (APVO) has disclosed Treasury Shares for 9 consecutive years, with $1.0 as the latest value for Q4 2024.

  • Quarterly Treasury Shares fell 99.43% to $1.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $1.0 through Dec 2024, down 99.43% year-over-year, with the annual reading at $1.0 for FY2024, 99.43% down from the prior year.
  • Treasury Shares hit $1.0 in Q4 2024 for Aptevo Therapeutics, down from $175.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $223775.0 in Q4 2022 to a low of $1.0 in Q4 2024.
  • Historically, Treasury Shares has averaged $46819.1 across 5 years, with a median of $12355.0 in 2020.
  • Biggest five-year swings in Treasury Shares: skyrocketed 531.22% in 2021 and later tumbled 99.92% in 2023.
  • Year by year, Treasury Shares stood at $9000.0 in 2020, then surged by 531.22% to $56810.0 in 2021, then skyrocketed by 293.9% to $223775.0 in 2022, then crashed by 99.92% to $175.0 in 2023, then crashed by 99.43% to $1.0 in 2024.
  • Business Quant data shows Treasury Shares for APVO at $1.0 in Q4 2024, $175.0 in Q4 2023, and $223775.0 in Q4 2022.